These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 36365164)

  • 1. Tumor Microenvironment-Based Stimuli-Responsive Nanoparticles for Controlled Release of Drugs in Cancer Therapy.
    Zhou W; Jia Y; Liu Y; Chen Y; Zhao P
    Pharmaceutics; 2022 Oct; 14(11):. PubMed ID: 36365164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-Acidity-Cleavable Maleic Acid Amide (TACMAA): A Powerful Tool for Designing Smart Nanoparticles To Overcome Delivery Barriers in Cancer Nanomedicine.
    Du JZ; Li HJ; Wang J
    Acc Chem Res; 2018 Nov; 51(11):2848-2856. PubMed ID: 30346728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimuli-Responsive Nanoparticles for Controlled Drug Delivery in Synergistic Cancer Immunotherapy.
    Zhang J; Lin Y; Lin Z; Wei Q; Qian J; Ruan R; Jiang X; Hou L; Song J; Ding J; Yang H
    Adv Sci (Weinh); 2022 Feb; 9(5):e2103444. PubMed ID: 34927373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor Microenvironment Responsive RNA Drug Delivery Systems: Intelligent Platforms for Sophisticated Release.
    Wang G; Zhang M; Lai W; Gao Y; Liao S; Ning Q; Tang S
    Mol Pharm; 2024 Jul; ():. PubMed ID: 39056442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy-shaping nanomedicine by loading Calcium Peroxide into Tumor Microenvironment-responsive Nanoparticles for the Antitumor Therapy of Prostate Cancer.
    Wu D; Zhu ZQ; Tang HX; Shi ZE; Kang J; Liu Q; Qi J
    Theranostics; 2020; 10(21):9808-9829. PubMed ID: 32863961
    [No Abstract]   [Full Text] [Related]  

  • 6. Tumor microenvironment responsive metal nanoparticles in cancer immunotherapy.
    Yang R; Chen L; Wang Y; Zhang L; Zheng X; Yang Y; Zhu Y
    Front Immunol; 2023; 14():1237361. PubMed ID: 37575228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimuli-Responsive Polymer-Based Nanosystems for Cancer Theranostics.
    Wei D; Sun Y; Zhu H; Fu Q
    ACS Nano; 2023 Dec; 17(23):23223-23261. PubMed ID: 38041800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimuli-responsive nanoassemblies for targeted delivery against tumor and its microenvironment.
    Sia CS; Lim HP; Tey BT; Goh BH; Low LE
    Biochim Biophys Acta Rev Cancer; 2022 Sep; 1877(5):188779. PubMed ID: 35977690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in intelligent-responsive nanocarriers for cancer therapy.
    Tian M; Xin X; Wu R; Guan W; Zhou W
    Pharmacol Res; 2022 Apr; 178():106184. PubMed ID: 35301111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smart Nanoplatforms Responding to the Tumor Microenvironment for Precise Drug Delivery in Cancer Therapy.
    Wang Y; Deng T; Liu X; Fang X; Mo Y; Xie N; Nie G; Zhang B; Fan X
    Int J Nanomedicine; 2024; 19():6253-6277. PubMed ID: 38911497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor Microenvironment-Responsive Drug Delivery Based on Polymeric Micelles for Precision Cancer Therapy: Strategies and Prospects.
    Jin Z; Al Amili M; Guo S
    Biomedicines; 2024 Feb; 12(2):. PubMed ID: 38398021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional block copolymer assemblies responsive to tumor and intracellular microenvironments for site-specific drug delivery and enhanced imaging performance.
    Ge Z; Liu S
    Chem Soc Rev; 2013 Sep; 42(17):7289-325. PubMed ID: 23549663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor Microenvironment Sensitive Nanocarriers for Bioimaging and Therapeutics.
    Park H; Saravanakumar G; Kim J; Lim J; Kim WJ
    Adv Healthc Mater; 2021 Mar; 10(5):e2000834. PubMed ID: 33073497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reactive oxygen species and glutathione dual responsive nanoparticles for enhanced prostate cancer therapy.
    Zhang L; Zhang S; Li M; Li Y; Xiong H; Jiang D; Li L; Huang H; Kang Y; Pang J
    Mater Sci Eng C Mater Biol Appl; 2021 Apr; 123():111956. PubMed ID: 33812584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in redox-responsive nanoparticles for combined cancer therapy.
    Yang Y; Sun W
    Nanoscale Adv; 2022 Aug; 4(17):3504-3516. PubMed ID: 36134355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor microenvironment-responsive nanozymes achieve photothermal-enhanced multiple catalysis against tumor hypoxia.
    Lv W; Cao M; Liu J; Hei Y; Bai J
    Acta Biomater; 2021 Nov; 135():617-627. PubMed ID: 34407474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrinsic stimuli-responsive nanocarriers for smart drug delivery of antibacterial agents-An in-depth review of the last two decades.
    Devnarain N; Osman N; Fasiku VO; Makhathini S; Salih M; Ibrahim UH; Govender T
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Jan; 13(1):e1664. PubMed ID: 32808486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Smart Dual-Stimuli Responsive Nanoparticles for Controlled Anti-Tumor Drug Release and Cancer Therapy.
    Wu F; Qiu F; Wai-Keong SA; Diao Y
    Anticancer Agents Med Chem; 2021; 21(10):1202-1215. PubMed ID: 32972353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Redox dual-stimuli responsive drug delivery systems for improving tumor-targeting ability and reducing adverse side effects.
    Li R; Peng F; Cai J; Yang D; Zhang P
    Asian J Pharm Sci; 2020 May; 15(3):311-325. PubMed ID: 32636949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimuli-responsive charge-reversal nano drug delivery system: The promising targeted carriers for tumor therapy.
    Fang Z; Pan S; Gao P; Sheng H; Li L; Shi L; Zhang Y; Cai X
    Int J Pharm; 2020 Feb; 575():118841. PubMed ID: 31812795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.